Martin F. Schacker

Amministratore Delegato presso Tetragenex Pharmaceuticals, Inc.

65 anni

Health Technology

Finance

Consumer Services

Posizioni attive di Martin F. Schacker

Società	Posizione	Inizio	Fine
Tetragenex Pharmaceuticals, Inc. Tetragenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetragenex Pharmaceuticals, Inc. operates as a biotechnology company. It develops and commercializes proprietary pharmaceutical products for use in treatment resistant depression and other central nervous system diseases in the United States. The firm's principal product is Nemifitide, an antidepressant compound, which is in Phase II clinical trials for the treatment of depression, anxiety, and other central nervous system disorders. The company was founded in 1989 and is headquartered in Syosset, NY.	Amministratore Delegato	05/02/2010	-
	Presidente	05/02/2010	-

Società	Posizione	Inizio	Fine
M.S. Farrell & Co., Inc.	Presidente	02/02/2001	02/02/2001
M.S. Farrell & Co., Inc.	Presidente	-	02/02/2001
D.H. Blair & Co.	Corporate Officer/Principal	02/12/1991	02/12/1991
Lehman Brothers Holdings Plc Lehman Brothers Holdings Plc Investment Banks/BrokersFinance Lehman Brothers Holdings Plc provides finance and treasury management services. The company is headquartered in London, UK.	Corporate Officer/Principal	02/05/1987	02/05/1987

Hofstra University

Undergraduate Degree

Distribuzione geografica

Stati Uniti	5
Regno Unito	2

Posizioni

Chairman	2
Corporate Officer/Principal	2
Chief Executive Officer	1

Settori

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Aziende private	4
Tetragenex Pharmaceuticals, Inc. Tetragenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetragenex Pharmaceuticals, Inc. operates as a biotechnology company. It develops and commercializes proprietary pharmaceutical products for use in treatment resistant depression and other central nervous system diseases in the United States. The firm's principal product is Nemifitide, an antidepressant compound, which is in Phase II clinical trials for the treatment of depression, anxiety, and other central nervous system disorders. The company was founded in 1989 and is headquartered in Syosset, NY.	Health Technology
M.S. Farrell & Co., Inc.
D.H. Blair & Co.
Lehman Brothers Holdings Plc Lehman Brothers Holdings Plc Investment Banks/BrokersFinance Lehman Brothers Holdings Plc provides finance and treasury management services. The company is headquartered in London, UK.	Finance